|Articles|October 7, 2022
- Pharmaceutical Commerce - October 2022
- Volume 17
- Issue 5
Pharmaceutical Commerce - October 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce October 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 3 years ago
Decisive Moves on the Digital Supply Chainabout 3 years ago
Betting the House on Orphan Drugsabout 3 years ago
Cold Chain Tech Continues to Evolveabout 3 years ago
Building a Robust Cold Chain for CGTsabout 3 years ago
Keys to CGT-Supply Chain Integrationabout 3 years ago
‘Old School,’ New Technologyabout 3 years ago
Building the Cold Chain of the Futureabout 3 years ago
Choosing the Right Monitoring Deviceabout 3 years ago
Global Logistics: A Cold Chain Blueprintabout 3 years ago
On the (New) Edge of TomorrowNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novo Nordisk’s Bloomington Plant Receives FDA OAI Designation Following Contamination and Compliance Issues
2
Why Regulatory Sandboxes Offer a Safe Space for AI Innovation in Healthcare
3
Pharma Pulse: CDC Layoffs Raise Public Health Concerns as Ypsomed and Lupin Expand US Manufacturing Footprint
4
LogiPharma USA 2025: What Topics Do You Think Will headline the 25th LogiPharma USA?
5
